Real-time enrollment status for this multiple myeloma, refractory clinical trial
Current Status
Recruiting
Checked: September 3, 2026 at 12:21 PM UTC
| NCT Number | NCT05546723 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma, Refractory |
| Phase | PHASE1 |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Luminary Therapeutics |
| Last Updated on CT.gov | October 18, 2024 (Oct 18, 2024) |
As of September 3, 2026: Clinical trial NCT05546723 is currently recruiting participants. This phase1 study for multiple myeloma, refractory is actively seeking new participants at 1 location across the United States. The study is sponsored by Luminary Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05546723 is actively recruiting participants as of September 3, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05546723 was last updated Oct 18, 2024 (October 18, 2024). HelloStudys verifies this status automatically.